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Abstract
Purpose: Adrenal scintigraphy with 131I-6b-iodomethyl-
norcholesterol is considered by several authors the gold
standard for assessing tumors with subclinical hypercor-
tisolemia. However, most of the described series consist
mainly of cases with unilateral lesions. The aim of our
study was to assess whether scintigraphy is useful in
choosing the adrenalectomy side in the case of bilateral
adrenal tumors with subclinical hypercortisolemia.
Methods: The study focused on 15 consecutive patients
with benign bilateral adrenal tumors and subclinical
hypercortisolemia. The scintigraphy with 131I-6b-
iodomethylnorcholesterol was performed. Fourteen pa-
tients underwent unilateral adrenalectomy; the gland
with predominant uptake on scintigraphy was removed.
Cortisol and ACTH concentrations were measured one
and six months after surgery. Post-dexamethasone cor-
tisolemia was assessed six months after surgery. To date,
the patients have been under postoperative observation
for 1–4 years.
Results: Four patients showed unilateral uptake of
radiotracer, and nine patients showed predominant
accumulation of radiotracer in one of the adrenal glands.
The smaller tumor was predominant in 2 cases. Percent-
age of activity on the predominant side correlates
positively with the difference between tumors’ diameters.
Unilateral uptake of radiotracer predicts long-lasting
postoperative insufficiency of the second adrenal gland.
Excision of predominating tumor led to cessation of
hypercortisolemia in all patients.
Conclusions: The corticoadrenal scintigraphy is useful in
choosing the side for operation in the case of bilateral
adrenal tumors with subclinical hypercortisolemia.
Key words: Adrenal scintigraphy—Bilateral adrenal
tumors—Iodomethylnorcholesterol
scintigraphy—Subclinical hypercortisolemia
Corticoadrenal scintigraphy (just as with every form of
scintigraphy) does not provide a perfect view on
morphology of the examined area and fails against
other imaging examinations in this respect. However, it
should be expected ﬁrst of all that scintigraphy pro-
vides an assessment of the examined tumor’s function
after a precise assessment of tumor morphology by X-
ray computed tomography (CT) or magnetic resonance
imaging (MRI). Scintigraphic imaging of the activity of
tumors originating from the adrenal cortex may com-
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plement or sometimes even replace catheterization of
adrenal veins in the case of aldosteronoma [1], but it
seems to be most useful in assessing cortisol-producing
adenomas of the adrenal fascicular zone. Scintigraphy
was considered the gold standard for assessing adrenal
tumors by several authors [2–4]; however, nowadays, it
is seldom used in diagnostics of incidentalomas. The
cholesterol derivative radiotracer, 131I-6b-iodomethyl-
norcholesterol ([131I]-NP-59) accumulates bilaterally in
healthy adrenal glands and unilaterally in hormonally
active adrenal adenomas or carcinomas [5]. Planar
radiographic technique with analysis of the regions of
interest (ROI) is the standard method of interpretation.
A less frequently employed but more accurate method
is using single-photon emission computed tomography
(SPECT). SPECT imaging may be useful, in particular,
in the diagnostics of ectopic adrenal glands, relapses at
the postoperative site or hormonally active metastases,
i.e., when an accurate imaging of the radiotracer
accumulation site is needed. After completion of a
dedicated CT or MRI of adrenal region, if there is still
need to confirm tumor hormonal activity, radionuclide
scintigraphy will be sufficient imaging modality [2, 5,
6].
Bilateral tumors constitute about 15% of incidentally
detected adrenal tumors [2, 7, 8]. They may cause overt
clinical or subclinical hypercortisolemia. Some authors
state that they have found a higher incidence of sub-
clinical Cushing’s syndrome among patients with benign
phenotype bilateral adrenal tumors compared to patients
with unilateral lesions [2, 8, 9].
Correct approval for surgical treatment is particu-
larly difﬁcult in case of bilateral lesions. There can only
be hormonal activity in one of the tumors; thus, it pays
to work out a method for unmistakably identifying the
hormonally active tumor that enables a unilateral in-
stead of bilateral adrenalectomy to be performed.
Catheterization of adrenal veins with determination of
the concentration gradient between them would be the
best method in such cases [10, 11]. However, it is an
invasive procedure, and patients with hypercortisolemia
are more at risk of complications, i.e., thrombosis in the
catheterized vessel or damage of the vessel, than others
[12]. In the case of bilateral lesions, it is most often
assumed that the larger tumor is the hormonally active
one; however, the dimensions of tumors differ slightly
in some patients. For assessment of incidentalomas,
some researchers have carried out radio-labeled norc-
holesterol scintigraphies that correlated well with adre-
nal cortex function [2–4], but in the series described in
their papers most of the tumors (85–95%) were unilat-
eral lesions.
The aim of our study was to assess whether scintig-
raphy is useful in choosing the adrenalectomy side in the
case of incidentally detected bilateral adrenal tumors
with subclinical hypercortisolemia.
Materials and methods
The material consisted of 15 patients with incidentally
discovered bilateral adrenal tumors and subclinical
hypercortisolemia. CT image phenotypes deﬁnitely cor-
responded to benign lesions in all the subjects: the values
of attenuation on unenhanced scans were <10 HU (-19
to +8 HU). None of the patients had evident somatic
features of hypercortisolemia, however, 13 patients had
hypertension, 5 had diabetes mellitus, and 10 had
hyperlipidemia. The adopted criterion for the diagnosis
of subclinical hypercortisolemia was a cortisolemia of
>3 mcg/dl after a dexamethasone suppression test and
ACTH concentration of <10 pg/ml (according to crite-
ria proposed by Eller Vanicher and coauthors [13]).
Subclinical hyperaldosteronism was ruled out by a cal-
culation of the PAC/PRA ratio and congenital adreno-
cortical hyperplasia by a determination of the 17-OH-
progesterone (17-OHP) concentration. Considering the
possibility of mixed tumors of the adrenal cortex and
medulla, all patients underwent a determination of 24-h
urinary excretion of methoxycatecholamines, which ru-
led out subclinical catecholamine hypersecretion.
Scintigraphy was performed 72 h after intravenous
administration of the radiotracer, and, in the case of
weak accumulation of the radiotracer, an additional time
after 144 h. No patients with subclinical hypercorti-
solemia underwent initial suppression with dexametha-
sone before scintigraphy. Thyroid iodine uptake was
blocked by oral administration of Lugol’s solution for
2 days. This examination was assessed with a semi-
quantitative method. The uptake patterns were classified
into four types:
type 1—no radiotracer uptake in the adrenal glands;
type 2—unilateral uptake without accumulation on the
contralateral side (100/0%).
type 3—bilateral uptake with distinctly predominant one
side (>66% of total activity): ‘‘predominant’’ = 66–
75% of total activity on the predominant side (70%
was assumed for calculations); ‘‘markedly predomi-
nant’’ = >75% of total activity on the predominant
side (85% was assumed for calculations);
type 4—bilateral symmetric uptake (L = R) (radiotracer
uptake of 50% in each tumor was assumed for calcu-
lations).
To evaluate the correlation between percent of uptake
and tumor diameters/hormone concentrations we used
Pearson’s analysis of correlation. Values were considered
statistically signiﬁcant at P < 0.05. The calculations
were performed by STATISTICATM.
Fourteen patients in the tested group underwent
unilateral laparoscopic adrenalectomy. The adrenal
gland with predominant uptake on scintigraphy was
operated, irrespectively whether it harbored the larger
tumor or not. In cases with symmetric uptake, the larger
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tumor was operated. Hydrocortisone was administered
parenterally at a dose of 150–200 mg/day on the day of
surgery and on day 1 and day 2, and then the treatment
was continued using an oral 30-mg/day administered in
two divided doses. The dose was tapered down individ-
ually according to patient’s clinical state (usually by 5 mg
every 1–2 weeks) at ambulatory visits.
During the second month after surgery, 24 h after the
last dose of hydrocortisone, a determination of cortisol
and ACTH concentration was carried out at 0800 h and
of cortisol at 2200 h, and then these concentrations were
determined half a year after surgery and every year from
then on. The dexamethasone suppression test with cor-
tisol concentration measurement was performed half a
year after surgery, then every year thereafter. The pa-
tients have been under postoperative observation for one
(two patients) to 4 years (7 patients), none of them had
the recurrence of hypercortisolemia.
Results
Four patients (27%) showed only unilateral uptake with
no radiotracer accumulation in the contralateral adrenal
gland 72 h after the administration of radiotracer
Fig. 1. Unilateral uptake of the tracer in the right adrenal gland (with the bigger tumor). a CT (the arrows point to the both
tumors); b anterior planar view of scintigraphic study; c posterior planar view.
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(Fig. 1). Predominant accumulation (>66% of total
activity) was demonstrated in one of the adrenal glands
in nine patients (60%) (Fig. 2). The uptake was sym-
metric in two patients (13%). The larger tumor was the
predominant one on scintigraphy in 11 cases, but pre-
dominant uptake was present in the smaller tumor with
trace accumulation on the contralateral side in two pa-
tients. A smaller by 1-cm tumor was predominant in one
case and smaller by 2.3 cm tumor in another case
(Fig. 3).
From an analysis of correlations it appeared that the
percentage of activity on the predominant side correlates
positively but weakly with the difference between tu-
mors’ diameters (r = 0.43; P = 0.06). After the exclu-
sion from the analysis of two patients with predominant
uptake in the smaller tumor, the correlation became
stronger (r = 0.62; P = 0.02) (Fig. 4). The percentage
of activity did not correlate with tumor size nor cortisol
nor ACTH concentrations.
Uptake in scintigraphy and postoperative
function of the adrenal gland
Unilateral uptake of radio-labeled norcholesterol with
complete uptake inhibition in the contralateral adrenal
gland was found in four patients (27%). The uptake was
Fig. 2. Predominant radiotracer accumulation (85%) in the left adrenal gland (with the bigger tumor). a, b CT (the arrows point
to the both tumors); c anterior planar view of scintigraphic study; d posterior planar view.
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present in the larger (by 1.2–4.5 cm) tumor in all the
cases. The cortisol concentration after the dexametha-
sone suppression test was on average 6.15 ± 1.2 mcg/dl
in these patients and did not differ significantly from that
in the other patients. One of these patients refused sur-
gery. Half a year after surgery, three patients with uni-
lateral uptake still presented with postoperative
insufficiency of the other adrenal gland, whereas the
other patients who were operated on already had normal
adrenal function. A secondary hypofunction of the
remaining adrenal gland was diagnosed based on per-
sisting inhibition of ACTH (<10 pg/ml), low concen-
trations of cortisol (<10 mcg/dl in the morning), low 24-
h urinary excretion of cortisol (<25 mcg/day), and 17-
hydroxy-corticosteroids (<2.2 mg/day) and clinical
symptoms (muscular pains, nausea, hypotension during
an attempt to withdraw hydrocortisone). Normal con-
centrations of ACTH and cortisol were found only
2 years after surgery in these patients.
Predominant uptake on one side with a slight uptake in
the contralateral adrenal gland was detected in nine pa-
tients (60%). Predominant uptake in the larger (by at
least 1 cm) tumor (1.1–3 cm) occurred in five patients,
whereas in two patients predominant uptake was present
in the smaller (by 1 and 2.3 cm) tumor. In two persons,
predominant uptake was detected in the tumor that was
only slightly larger in diameter (a difference of 0.5 and
0.6 cm, respectively). The concentrations of cortisol were
low (<10 mcg/dl), and the concentrations of ACTH still
remained below the lower normal range (i.e., below
Fig. 3. Predominant uptake in the left, smaller tumor with trace accumulation in the right (harbouring the bigger lesion) adrenal
gland. a CT (the arrows point to the both tumors); b anterior planar view of scintigraphic study; c posterior planar view.
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10 pg/ml) in all patients during the second month after
surgery. Therefore, a strategy consisting of a gradual
hydrocortisone dose decrease was employed. None of the
patients had a secondary adrenocortical insufficiency
after the withdrawal of hydrocortisone half a year after
surgery.
Symmetric bilateral uptake was found in two patients
(13%) in whom the difference between tumors’ diameters
was 0.3 and 1 cm. The larger tumor was operated on
first. These patients had no secondary adrenal insuffi-
ciency after the adrenalectomy, In one of them, after
6 months, the ACTH concentration was low, and the
cortisol concentration was too high (3.6 mcg/dl) after
dexamethasone suppression test. This patient gained
weight of 5 kg and, as before surgery, has treatment-
resistant arterial hypertension. Repeated scintigraphy
during the administration of dexamethasone showed
radiotracer uptake in the non-operated left adrenal
gland. As histology revealed a nodular hyperplasia in the
excised right adrenal gland, the surgeon decided to per-
form a total adrenalectomy. A reduction in arterial
pressure values and a continuous loss of body mass
(12 kg in total during 2 years) was achieved after the
second surgical procedure; this patient receives at present
15–20 mg of hydrocortisone daily.
Proper cortisol concentrations after dexamethasone
suppression were found after the consecutive 1 and
2 years in all patients.
The individual results for each patient are shown in
Table 1.
Discussion
Correct clinical evaluation and exact analysis of hor-
monal tests carried out in the patients before surgery
warrant effectiveness of the operation. In considering the
criteria for approval of surgical treatment in patients
with subclinical hypercortisolemia, Eler-Vainicher
Fig. 4. Percentage of activity on the predominant side cor-
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emphasizes that postoperative secondary insufﬁciency of
the other adrenal gland is deﬁnitive proof of tumor
hormonal activity [14]. The majority of papers regarding
the indication to adrenalectomy discuss the hormonal
criteria which must be fulfilled to make a decision about
surgery. At least two of the following abnormal results
should be found: a cortisol concentration of >3 mcg/dl
after dexamethasone, an ACTH concentration of
<10 pg/ml, a cortisol concentration of >4 mcg/dl at
midnight, and 24-h urinary excretion of free cortisol of
>70 mcg [13, 15–17]. In our study, we decided to use the
first two hormonal criteria as the simplest ones with re-
spect to execution and repetition, as well as in ambula-
tory settings. However, even an unquestionable diagnosis
of hypercortisomia in the case of bilateral tumors did not
ensure successful surgery because the lateralization of
secretory function still remained unclear.
Accumulation of radiolabelled norcholesterol in the
adrenal glands is evidence of adrenocortical hormonal
activity. Therefore, we considered scintigraphy to be
potentially valuable for choosing the adrenal gland for
surgery in the case of bilateral lesions and subclinical
hypercortisolemia. Scintigraphy was considered to be the
gold standard for assessing incidentalomas by several
authors [2–4]; however, in the series described in their
papers, most of the tumors (85–95%) were unilateral le-
sions. A unilateral radiotracer uptake was found in all
the cases of cortisol concentration of >5 mcg/dl after
dexamethasone suppression test and such uptake pre-
dicted insufficiency of the second adrenal gland after
surgery [2, 3]. In our study, a postoperative insufficiency
of the second adrenal gland lasting two years occurred in
3 of 4 patients with only unilateral uptake (the fourth
person refused surgery), and the preoperative cortisol
concentration after dexamethasone suppression test was
above 5 mcg/dl in three of these patients. Furthermore,
postoperative decrease in cortisolemia did not occur in
the two cases of bilateral uptake, and a deteriorated
clinical state (increment of body mass, poor control of
arterial hypertension), an abnormal dexamethasone
suppression test, and a low concentration of ACTH
6 months after surgery were the indication for the second
adrenalectomy in one of these patients. On the other
hand, the other patient with symmetric radiotracer up-
take in whom hydrocortisone was already discontinued
during the second month after surgery did not require
repeated surgery. Her post-dexamethasone cortisol con-
centration was borderline (2.6 mcg/dl), and neither an
inhibition of ACTH release nor deteriorated general
condition was observed in this patient. The above finding
is consistent with the results of several studies in which
an improvement of the clinical state following the re-
moval of one of the tumors was observed even in the
presence of symmetric uptake on scintigraphy without
postoperative insufficiency of the other adrenal gland;
thus, the hormonal function was certainly bilateral be-
fore surgery [18, 19].
In the group described by Iacobone that consisted of
seven patients with differences between tumors’ diame-
ters of >2 cm who underwent resection of the adrenal
gland harboring the larger tumor and showing predom-
inant uptake of labeled norcholesterol, a marked clinical
improvement was achieved in six patients, including two
patients with permanent secondary insufﬁciency of the
other adrenal gland [18]. The surgical treatment was not
successful in case of similar dimensions of enlarged
adrenals, which was accompanied with symmetric uptake
of NP-59. The correlation between the percentage of
radiotracer uptake by the predominant adrenal gland on
scintigraphy and the difference between tumors’ diame-
ters discovered by us also supports the thesis that the
greater the difference between lesions’ dimensions, the
greater the difference in secretory activity. However, in
individual cases the bigger size was not always evidence
of tumor secretory activity: in two patients smaller tu-
mors were predominant on scintigraphy (difference be-
tween diameters of 2.3 and 1 cm), and in two other
patients the only slightly larger tumor was predominant
(difference 0.6 and 0.5 cm). The literature regarding
bilateral adrenal tumors indicated that tumors larger by
at least 1 cm should be operated on when unilateral
adrenalectomy is performed [18–20]; thus, the non-se-
creting side would be operated in the two first persons. If
the difference between diameters is less than 1 cm, a
selective bilateral excision of fragments of adrenal glands
harboring focal lesions is often performed [21–23];
however, execution of such a surgical procedure in two
patients would be unnecessary. In addition, histopatho-
logical examination showed a macronodular hyperplasia
in these female patients; thus, they were at high risk of
new focal lesions in the remaining fragments of adrenal
glands.
Conclusion
Corticoadrenal scintigraphy is useful in choosing the
operation side in the case of bilateral adrenal tumors
with subclinical hypercortisolemia. Unilateral radio-
tracer uptake on scintigraphy predicts a long-lasting
insufﬁciency of the other adrenal gland after surgery.
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